We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Haematology
Digital Poster
Clinical
Is the mean heart dose the best predictor of cardiac toxicity after Hodgkin Lymphoma irradiation?
Rim Moujahed, Tunisia
PO-1074
Bridging Radiotherapy prior to Brexucabtagene Autoleucel CAR T-Cell Therapy in Mantle Cell Lymphoma
Nicholas Figura, USA
PO-1075
Hypofractionated Total Marrow Irradiation in second allogeneic hematopoietic stem cell transplantats
Stefano Vagge, Italy
PO-1076
Population-based study on the association between autoimmune disease and lymphoma in Korea
Jae Sik Kim, Korea Republic of
PO-1077
HDR brachytherapy for treatment of primary cutaneous lymphoma at complex sites and curved surfaces
Van Sim, United Kingdom
PO-1078
Do you use RT as part of bridging therapy for the treatment of DLBCL with CAR-T cells?
Cristina Prieto Prieto, Spain
PO-1079
Low-dose radiotherapy (4 Gy) in the treatment of marginal zone B- cell lymphomas
Marzia Cerrato, Italy
PO-1080
Effectiveness and tolerability of radiotherapy for patients with diffuse large cell B-cell lymphoma
Indrawati Hadi, Germany
PO-1081
Predicted cardiac and second cancer risks following treatment for Hodgkin lymphoma in Ireland
Orla Houlihan, United Kingdom
PO-1082